Some more investigation from Bob Fiddaman at Seroxat Sufferers, this time involving Glaxo and its Asthma drug Seretide, in Australia. See the whole post here.
Meet Puff the purple dragon. Last year Puff became the public face of a new National Asthma Council awareness campaign to encourage asthmatics to better manage their medications.
But Puff had an earlier existence. He began life as the registered trademark used by international pharmaceutical giant GlaxoSmithKline to market one of its asthma drugs, Seretide, to doctors. His colour matches the packaging for Seretide.
GlaxoSmithKline, which is the world’s biggest seller of asthma medications, also provided financial support for the television campaign and to develop an interactive internet quiz for the NAC website to check whether someone’s asthma was under control. Even if you answer “no” to the initial question “do you have asthma?” and say you have no symptoms, Puff advises you that your asthma appears to be under control, but you should visit your doctor anyway for a medical review.
No conflicts of interest here, then…